LAWRENCE LEE: Open Payments
NPI 1063424935 · ALABASTER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,394 in 132 payments from 23 companies in 2025. Trend: 2023 $2,069 · 2024 $2,678 · 2025 $2,394
Food & beverage: $2,382Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $332 |
| PFIZER INC. | 15 | $301 |
| AstraZeneca Pharmaceuticals LP | 12 | $257 |
| Otsuka America Pharmaceutical, Inc. | 12 | $201 |
| Axsome Therapeutics, Inc. | 6 | $166 |
| Novo Nordisk Inc | 8 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $135 |
| Exact Sciences Corporation | 6 | $104 |
| GlaxoSmithKline, LLC. | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
Products named: REXULTI, NURTEC ODT, Auvelity, CAPLYTA, VRAYLAR, BREZTRI, QULIPTA, FARXIGA.
Industry payments across AL — which companies pay providers there.
